This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1999 May;1(3):127-36.

doi: 10.1046/j.1463-1326.1999.00026.x.

The polycystic ovary syndrome: treatment with insulin sensitizing agents

M J Iuorno¹, J E Nestler

Affiliations

PMID: 11220291
DOI: 10.1046/j.1463-1326.1999.00026.x

Review

The polycystic ovary syndrome: treatment with insulin sensitizing agents

M J Iuorno et al. Diabetes Obes Metab. 1999 May.

. 1999 May;1(3):127-36.

doi: 10.1046/j.1463-1326.1999.00026.x.

Authors

M J Iuorno¹, J E Nestler

Affiliation

¹ Department of Internal Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0111, USA.

PMID: 11220291
DOI: 10.1046/j.1463-1326.1999.00026.x

No abstract available

PubMed Disclaimer

Similar articles

Insulin sensitizers for polycystic ovary syndrome.
Baillargeon JP, Iuorno MJ, Nestler JE. Baillargeon JP, et al. Clin Obstet Gynecol. 2003 Jun;46(2):325-40. doi: 10.1097/00003081-200306000-00011. Clin Obstet Gynecol. 2003. PMID: 12808383 Review. No abstract available.
Insulin sensitizers and antiandrogens in the treatment of polycystic ovary syndrome.
Diamanti-Kandarakis E, Zapanti E. Diamanti-Kandarakis E, et al. Ann N Y Acad Sci. 2000;900:203-12. doi: 10.1111/j.1749-6632.2000.tb06231.x. Ann N Y Acad Sci. 2000. PMID: 10818407
Insulin-sensitising agents in polycystic-ovary syndrome.
Sattar N, Hopkinson ZE, Greer IA. Sattar N, et al. Lancet. 1998 Jan 31;351(9099):305-7. doi: 10.1016/S0140-6736(05)78345-8. Lancet. 1998. PMID: 9652605 No abstract available.
Switching insulin-sensitizing agents in patients with type 2 diabetes who require insulin.
Blonde L, Sandberg MI, Guthrie RD Jr. Blonde L, et al. Diabetes Care. 1999 Jun;22(6):1004-6. doi: 10.2337/diacare.22.6.1004a. Diabetes Care. 1999. PMID: 10372262 No abstract available.
[Troglitazone for treatment of polycystic ovary syndrome].
Sanaka M, Iwamoto Y. Sanaka M, et al. Nihon Rinsho. 2000 Feb;58(2):465-70. Nihon Rinsho. 2000. PMID: 10707578 Review. Japanese.

See all similar articles

Cited by

Obesity, Height, and Serum Androgen Metabolism among Postmenopausal Women in the Women's Health Initiative Observational Study.
Oh H, Wild RA, Manson JE, Bea JW, Shadyab AH, Pfeiffer RM, Saquib N, Underland L, Anderson GL, Xu X, Trabert B. Oh H, et al. Cancer Epidemiol Biomarkers Prev. 2021 Nov;30(11):2018-2029. doi: 10.1158/1055-9965.EPI-21-0604. Epub 2021 Aug 26. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 34446472 Free PMC article.
Treatment with Myo-Inositol and Selenium Ensures Euthyroidism in Patients with Autoimmune Thyroiditis.
Nordio M, Basciani S. Nordio M, et al. Int J Endocrinol. 2017;2017:2549491. doi: 10.1155/2017/2549491. Epub 2017 Feb 15. Int J Endocrinol. 2017. PMID: 28293260 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

R01HD35629/HD/NICHD NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Wiley
Medical
- MedlinePlus Health Information